Inventor · disambiguated record
Donald C. Foster
Also filed as: FOSTER DONALD · FOSTER DONALD C · FOSTER DONALD CRAIG
114 granted patents·36 pending applications·3,782 citations·filing 1985–2024
99Inventor score
Files withZYMOGENETICS INC69ALNYLAM PHARMACEUTICALS INC25AMKOR TECHNOLOGY INC19UNIV WASHINGTON7GENZYME CORP3
Top patents by PatentIndex Score
150 records- 0199US6818973B1Exposed lead QFP package fabricated through the use of a partial saw processAMKOR TECHNOLOGY INC·Filed 2002·Granted Nov 16, 2004·203 cites·30 claims
- 0299US6686178B2Cytokine zalpha11 ligand polynucleotidesZYMOGENETICS INC·Filed 2002·Granted Feb 3, 2004·113 cites·24 claims
- 0399US6605272B2Methods of using zalpha11 ligandZYMOGENETICS INC·Filed 2001·Granted Aug 12, 2003·117 cites·21 claims
- 0499US6307024B1Cytokine zalpha11 LigandZYMOGENETICS INC·Filed 2000·Granted Oct 23, 2001·232 cites·23 claims
- 0598US9249415B2Complement component C5 iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2015·Granted Feb 2, 2016·24 cites·30 claims
- 0698US7629674B1Shielded package having shield fenceAMKOR TECHNOLOGY INC·Filed 2004·Granted Dec 8, 2009·141 cites·10 claims
- 0797US11015201B2Angiotensinogen (AGT) iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2020·Granted May 25, 2021·6 cites·15 claims
- 0897US8362597B1Shielded package having shield lidAMKOR TECHNOLOGY INC·Filed 2009·Granted Jan 29, 2013·35 cites·13 claims
- 0997US7211471B1Exposed lead QFP package fabricated through the use of a partial saw processAMKOR TECHNOLOGY INC·Filed 2004·Granted May 1, 2007·114 cites·20 claims
- 1097US6995459B2Semiconductor package with increased number of input and output pinsAMKOR TECHNOLOGY INC·Filed 2005·Granted Feb 7, 2006·129 cites·20 claims
- 1196US11873491B2Complement component C5 iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2021·Granted Jan 16, 2024·2 cites·32 claims
- 1296US11504391B1Modified RNA agents with reduced off-target effectALNYLAM PHARMACEUTICALS INC·Filed 2017·Granted Nov 22, 2022·18 cites·42 claims
- 1396US9850488B2Complement component C5 iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2015·Granted Dec 26, 2017·11 cites·62 claims
- 1496US9701963B2Complement component C5 iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2016·Granted Jul 11, 2017·9 cites·32 claims
- 1596US9127274B2Serpinc1 iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS·Filed 2013·Granted Sep 8, 2015·51 cites·62 claims
- 1696US8552539B1Shielded package having shield lidAMKOR TECHNOLOGY INC·Filed 2013·Granted Oct 8, 2013·17 cites·18 claims
- 1796US7473765B2Cytokine zalpha11 ligandZYMOGENETICS INC·Filed 2003·Granted Jan 6, 2009·29 cites·8 claims
- 1896US7245007B1Exposed lead interposer leadframe packageAMKOR TECHNOLOGY INC·Filed 2003·Granted Jul 17, 2007·129 cites·15 claims
- 1995US11834661B2Angiotensinogen (AGT) iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2021·Granted Dec 5, 2023·2 cites·65 claims
- 2095US8110180B2Method of use of cytokine ZALPHA11 ligandNOVAK JULIA E·Filed 2006·Granted Feb 7, 2012·19 cites·22 claims
- 2195US6876068B1Semiconductor package with increased number of input and output pinsAMKOR TECHNOLOGY INC·Filed 2003·Granted Apr 5, 2005·108 cites·24 claims
- 2295US6610286B2Method for treating inflammation using soluble receptors to interleukin-20ZYMOGENETICS INC·Filed 2000·Granted Aug 26, 2003·52 cites·15 claims
- 2395US6603072B1Making leadframe semiconductor packages with stacked dies and interconnecting interposerAMKOR TECHNOLOGY INC·Filed 2001·Granted Aug 5, 2003·162 cites·33 claims
- 2494US11419942B2Angiotensinogen (AGT) iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2020·Granted Aug 23, 2022·2 cites·55 claims
- 2594US10995336B2Serpina1 iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2019·Granted May 4, 2021·8 cites·41 claims
- 2694US10238749B2Angiotensinogen (AGT) iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2015·Granted Mar 26, 2019·12 cites·44 claims
- 2794US8551820B1Routable single layer substrate and semiconductor package including sameFOSTER DONALD CRAIG·Filed 2009·Granted Oct 8, 2013·51 cites·19 claims
- 2894US7572892B2Cytokine zalpha11 ligand fusion proteinsZYMOGENETICS INC·Filed 2006·Granted Aug 11, 2009·6 cites·4 claims
- 2993USRE41129ECytokine zalpha11 ligand polynucleotidesZYMOGENETICS INC·Filed 2006·Granted Feb 16, 2010·7 cites·142 claims
- 3093US6087473AKunitz domain polypeptide and materials and methods for making itZYMOGENETICS INC·Filed 1999·Granted Jul 11, 2000·76 cites·8 claims
- 3193US5639940AProduction of fibrinogen in transgenic animalsPHARMACEUTICAL PROTEINS LTD·Filed 1994·Granted Jun 17, 1997·129 cites·33 claims
- 3293US5225537AMethods for producing hybrid phospholipid-binding proteinsZYMOGENETICS INC·Filed 1989·Granted Jul 6, 1993·103 cites·5 claims
- 3392US10814007B2Angiotensinogen (AGT) iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2019·Granted Oct 27, 2020·3 cites·15 claims
- 3492US7611699B2Methods of using cytokine zalpha11 ligandZYMOGENETICS INC·Filed 2006·Granted Nov 3, 2009·6 cites·11 claims
- 3592US6656746B2Antibodies to human kunitz-type inhibitorZYMOGENETICS INC·Filed 2001·Granted Dec 2, 2003·34 cites·31 claims
- 3692US6627977B1Semiconductor package including isolated ring structureAMKOR TECHNOLOGY INC·Filed 2002·Granted Sep 30, 2003·69 cites·32 claims
- 3792US6552416B1Multiple die lead frame package with enhanced die-to-die interconnect routing using internal lead trace wiringAMKOR TECHNOLOGY INC·Filed 2000·Granted Apr 22, 2003·76 cites·41 claims
- 3892US6437449B1Making semiconductor devices having stacked dies with biased back surfacesAMKOR TECHNOLOGY INC·Filed 2001·Granted Aug 20, 2002·75 cites·20 claims
- 3991US10829763B2TMPRSS6 iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2019·Granted Nov 10, 2020·4 cites·17 claims
- 4091US9376680B2Serpinc1 iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2015·Granted Jun 28, 2016·7 cites·55 claims
- 4191US5925735AHematopoietic cytokine receptorZYMOGENETICS INC·Filed 1998·Granted Jul 20, 1999·89 cites·12 claims
- 4291US5441931AHuman amyloid protein precursor homologue and Kunitz-type inhibitorsFiled 1993·Granted Aug 15, 1995·82 cites·3 claims
- 4390US11162098B2Complement component C5 iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2019·Granted Nov 2, 2021·2 cites·19 claims
- 4490US7569670B2Cytokine zalpha11 ligand fusion proteinsZYMOGENETICS INC·Filed 2006·Granted Aug 4, 2009·4 cites·4 claims
- 4590US6429513B1Active heat sink for cooling a semiconductor chipAMKOR TECHNOLOGY INC·Filed 2001·Granted Aug 6, 2002·76 cites·48 claims
- 4689US9123718B1Shielded package having shield lidAMKOR TECHNOLOGY INC·Filed 2013·Granted Sep 1, 2015·7 cites·20 claims
- 4789US7829075B2Method for expanding hematopoietic cells using cytokine zalpha11 ligandZYMOGENETICS INC·Filed 2006·Granted Nov 9, 2010·2 cites·5 claims
- 4889US2025064943A1ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOFALNYLAM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4988US11725207B2Serpina1 iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2021·Granted Aug 15, 2023·1 cites·123 claims
- 5088US10246713B2TMPRSS6 iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2017·Granted Apr 2, 2019·6 cites·14 claims
Showing the top 50 of 150 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Donald C. Foster files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →